Drug Neurology

Zembrace Symtouch

Payments companies reported to CMS as associated with Zembrace Symtouch. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$222Kassociated payments (2023-2025)
1,799clinicians with associated payments
3companies reporting

By year

2023 $123K
2024 $63K
2025 $36K

Payments reported as associated with Zembrace Symtouch, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $120K
Physician Assistant $16K
Family $14K
Nurse Practitioner $13K
Internal Medicine $9,606
Adult Health (Nurse Practitioner) $7,976

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Zembrace Symtouch

These are the largest totals companies reported as associated with Zembrace Symtouch. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Marshall Freeman Greensboro, NC Neurology (Psychiatry & Neurology) $18,345.51
Peter Mcallister Fairfield, CT Neurology (Psychiatry & Neurology) $8,090.50
Susan Hutchinson Laguna Hills, CA Adult Medicine $6,121.64
Christina Treppendahl Ridgeland, MS Nurse Practitioner $5,701.75
Stewart Tepper Stamford, CT Neurology (Psychiatry & Neurology) $4,803.25
Lauren Jendraszek Amherst, NY Physician Assistant $4,136.29
Jack Schim Carlsbad, CA Neurology (Psychiatry & Neurology) $3,982.56
Stephanie Nahas-Geiger Philadelphia, PA Neurology (Psychiatry & Neurology) $3,797.46
Andrew Blumenfeld Carlsbad, CA Neurology (Psychiatry & Neurology) $3,766.42
Jessica Ailani Washington, DC Neurology (Psychiatry & Neurology) $3,648.81

Prescribed Zembrace Symtouch?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.